About us

Start ] [ About us ] References ] Products ] Quality Control ] Questions and Answers ] Microcarriers ] Application Notes ] Picture Gallery ]

 

Foundation Founded in 1987, Percell Biolytica is one of Sweden's oldest biotech companies.


Our mission

We are committed to the development, production, and commercialization of CultiSpher macroporous microcarriers. 


Collaborations and agreements

Strategic collaborations and agreements are key elements of our growth strategy.

Titan Pharmaceutical Inc.
Production of a proprietary microcarrier for Spheramine™. Spheramine™, is a cell based product for the treatment of Parkinson's disease, which utilize non-embryonic, human retinal pigment epithelial (RPE) cells. RPE cells produce dopamine, a neurotransmitter that is lacking in certain brain regions in Parkinson's disease. The product consist of human RPE cells adhered to this proprietary microcarrier which allow for the long term survival and function of cells that are implanted into the mammalian central nervous system. Murine and primate animal studies have demonstrated the ability of a single treatment to significantly reverse Parkinson's like symptoms up to one year. In a report, presented at the 55th Annual meeting of American Academy of Neurology, major improvements were found in a group of six patients with advanced Parkinson disease. View and downloand press releases, PDF-files, from Titan Pharmaceutical Inc.:

 

European Craft Project, Bio-artificial Pancreas
Industrial partners: Percell Biolytica (Sweden), Computer Cell Culture Centre (Belgium), Laboratoire Perouse Implant (France), Statice Sante (France) and Medisolve (Germany).
Research partners: Centre Europeen d Étude du Diabete (France), Université Libre de Bruxelles (Belgium), Centre de Transfert de Technologie du Mans (France), Universite Catholique de Louvain (France) and Universita Degli Studi di Pisa (Italy).
The project aim was to develop a small scale prototype of bio-artificial pancreas usable in the human. The bio-artificial pancreas will be made of Langerhans islets (responsible for insulin secretion in pancreas) packed in a capsule made of a complex support and a semi permeable membrane. The Langerhans islets can either be used intact or dissociated into individual cells. Download a project summary, PDF-file: The Plastic Pancreas


Trademark

CultiSpher® is a registered trademark.


Patents

The manufacture of CultiSpher microcarriers is a patented process. This process is covered by the following patents:
  • United States: 4,935,365 / 5,015,576
  • Germany: DE 36 89 327
  • Japan: 2118094
  • Sweden: 5047645
  • France: 222718
  • United Kingdom:  222718


Contact information

Address: Ji-Te gatan 9, S-265 38 Åstorp, Sweden
Phone: +46-42-502 82
Fax: +46-42-501 91
E-mail: kjell.nilsson@percell.se